Cerity Partners LLC Novartis Ag Transaction History

Cerity Partners LLC

  • $44.7 Billion
  • Q3 2024

A detailed history of Cerity Partners LLC transactions in Novartis Ag stock. As of the latest transaction made, Cerity Partners LLC holds 315,488 shares of NVS stock, worth $31.3 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
315,488
Previous 269,256 17.17%
Holding current value
$31.3 Million
Previous $28.7 Million 26.59%
% of portfolio
0.08%
Previous 0.08%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$106.13 - $120.89 $4.91 Million - $5.59 Million
46,232 Added 17.17%
315,488 $36.3 Million
Q2 2024

Aug 13, 2024
SELL
$92.57 - $107.37 $1.66 Million - $1.92 Million
-17,920 Reduced 6.24%
269,256 $28.7 Million
Q1 2024

May 14, 2024
BUY
$95.27 - $108.47 $3.75 Million - $4.27 Million
39,375 Added 15.89%
287,176 $27.8 Million
Q4 2023

Jan 26, 2024
BUY
$92.27 - $101.54 $5.39 Million - $5.93 Million
58,395 Added 30.83%
247,801 $25 Million
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $3.65 Million - $4.05 Million
-38,567 Reduced 16.92%
189,406 $19.3 Million
Q2 2023

Aug 14, 2023
BUY
$92.52 - $104.91 $318,823 - $361,519
3,446 Added 1.53%
227,973 $23 Million
Q1 2023

May 11, 2023
BUY
$80.03 - $92.81 $12.5 Million - $14.5 Million
156,290 Added 229.04%
224,527 $20.7 Million
Q4 2022

Feb 15, 2023
BUY
$75.55 - $92.52 $2.14 Million - $2.63 Million
28,376 Added 71.19%
68,237 $6.19 Million
Q3 2022

Nov 10, 2022
BUY
$74.61 - $87.26 $85,204 - $99,650
1,142 Added 2.95%
39,861 $3.03 Million
Q2 2022

Aug 10, 2022
BUY
$80.52 - $93.75 $1.19 Million - $1.38 Million
14,764 Added 61.63%
38,719 $3.27 Million
Q1 2022

Apr 25, 2022
BUY
$80.11 - $90.62 $90,123 - $101,947
1,125 Added 4.93%
23,955 $1.85 Million
Q4 2021

Feb 14, 2022
BUY
$79.7 - $88.13 $793,572 - $877,510
9,957 Added 77.35%
22,830 $1.99 Million
Q3 2021

Oct 25, 2021
SELL
$81.78 - $95.14 $56,673 - $65,932
-693 Reduced 5.11%
12,873 $1.05 Million
Q2 2021

Aug 11, 2021
SELL
$85.24 - $94.15 $111,067 - $122,677
-1,303 Reduced 8.76%
13,566 $1.24 Million
Q1 2021

Aug 11, 2021
SELL
$83.5 - $98.47 $26,970 - $31,805
-323 Reduced 2.13%
14,869 $1.27 Million
Q1 2021

May 12, 2021
SELL
$83.5 - $98.47 $126,669 - $149,378
-1,517 Reduced 9.08%
15,192 $1.3 Million
Q4 2020

Feb 11, 2021
SELL
$78.07 - $94.43 $60,894 - $73,655
-780 Reduced 4.46%
16,709 $1.58 Million
Q3 2020

Nov 12, 2020
BUY
$82.14 - $91.0 $77,129 - $85,449
939 Added 5.67%
17,489 $1.52 Million
Q2 2020

Aug 17, 2020
SELL
$80.93 - $91.1 $20,637 - $23,230
-255 Reduced 1.52%
16,550 $1.45 Million
Q2 2020

Aug 14, 2020
SELL
$80.93 - $91.1 $162,183 - $182,564
-2,004 Reduced 10.65%
16,805 $1.47 Million
Q1 2020

May 14, 2020
SELL
$70.67 - $99.01 $51,659 - $72,376
-731 Reduced 3.74%
18,809 $1.55 Million
Q4 2019

Feb 14, 2020
SELL
$84.35 - $95.37 $169,712 - $191,884
-2,012 Reduced 9.34%
19,540 $1.85 Million
Q3 2019

Oct 30, 2019
BUY
$85.54 - $94.26 $227,450 - $250,637
2,659 Added 14.07%
21,552 $1.87 Million
Q2 2019

Aug 14, 2019
SELL
$75.4 - $92.8 $589,854 - $725,974
-7,823 Reduced 29.28%
18,893 $1.73 Million
Q1 2019

May 14, 2019
SELL
$75.32 - $86.15 $595,028 - $680,585
-7,900 Reduced 22.82%
26,716 $2.57 Million
Q4 2018

Feb 06, 2019
BUY
$73.66 - $82.02 $56,497 - $62,909
767 Added 2.27%
34,616 $2.97 Million
Q3 2018

Nov 15, 2018
BUY
$66.94 - $77.43 $39,293 - $45,451
587 Added 1.76%
33,849 $2.92 Million
Q2 2018

Aug 15, 2018
SELL
$64.91 - $73.36 $81,851 - $92,506
-1,261 Reduced 3.65%
33,262 $2.51 Million
Q1 2018

May 15, 2018
BUY
$70.39 - $84.15 $2.43 Million - $2.91 Million
34,523 New
34,523 $2.79 Million
Q4 2017

Feb 14, 2018
SELL
$72.33 - $77.64 $2.78 Million - $2.98 Million
-38,369 Closed
0 $0
Q3 2017

Nov 13, 2017
BUY
$74.14 - $77.27 $2.84 Million - $2.96 Million
38,369
38,369 $3.29 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $213B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email